Hct (Hydrochlorothiazide)

Hydrochlorothiazide is indicated for several cardiovascular and renal conditions where reduction of fluid volume or blood pressure is desired.

• Hypertension (high blood pressure) management, often as first‑line therapy or in combination with other antihypertensives.
• Edema associated with congestive heart failure, providing symptomatic relief by promoting diuresis.
• Fluid retention secondary to liver cirrhosis, helping to reduce abdominal swelling.
• Edematous states related to chronic kidney disease, assisting in volume control.
• Occasionally used off‑label for calcium‑containing kidney stones prevention (under physician supervision).

Like other thiazide diuretics, hydrochlorothiazide may cause a range of adverse effects, most of which are mild and reversible.

Common

• Increased urination and mild dehydration.
• Electrolyte disturbances such as low potassium (hypokalemia) or low sodium (hyponatremia).
• Elevated blood glucose levels, particularly in patients with diabetes.
• Gout attacks due to higher uric acid concentrations.
• Dizziness or light‑headedness, especially after standing.

Serious

• Severe electrolyte imbalance leading to muscle cramps or cardiac arrhythmias.
• Acute kidney injury manifested by sudden rise in serum creatinine.
• Allergic reactions including rash, itching, or angioedema.
• Pancreatitis, though rare, presenting with abdominal pain and nausea.

Before initiating therapy with hydrochlorothiazide, healthcare providers assess several clinical factors to minimize risks.

• Baseline kidney function and serum electrolytes should be measured.
• Patients with a history of gout or hyperuricemia may require monitoring.
• Caution is advised in individuals with diabetes due to possible glucose elevation.
• Concomitant use of other diuretics or NSAIDs can increase the risk of renal impairment.
• Pregnant or breastfeeding women should discuss potential benefits and risks with their clinician.
• Elderly patients may be more susceptible to orthostatic hypotension and dehydration.

Hydrochlorothiazide can alter the pharmacokinetics or pharmacodynamics of several medicines; awareness of these interactions helps avoid adverse outcomes.

Avoid

• Concurrent use with lithium, which may raise lithium levels and cause toxicity.
• Combination with other potent diuretics (e.g., loop diuretics) that can precipitate severe electrolyte loss.
• Co‑administration with ACE inhibitors or ARBs in patients prone to renal dysfunction without close monitoring.

Use with caution

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may reduce diuretic effectiveness and affect kidney function.
• Antidiabetic agents, as hydrochlorothiazide can increase blood glucose.
• Cardiac glycosides (e.g., digoxin) because electrolyte shifts may enhance toxicity.